Trial
NCT03094169
AVID100 in Advanced Epithelial Carcinomas
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Formation Biologics
Collaborators
—
Condition
Solid Tumor, Adult
Intervention
AVID100 IV
Why stopped
lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-11